| | Over a decade in the making, CAR T-Cell Therapy has proven to be one of the more innovative and promising treatments in oncology. Learn more about what companies should consider when it comes to this cutting edge treatment from a free white paper by TD2. |
Pfizer, BioNTech start their COVID-19 vax phase 3, squaring off with Moderna European cancer biotech Merus nabs Sanofi I-O chief Andrew Joe Bright Peak Therapeutics debuts with $35M, cytokine pipeline, ex-Astellas CMO at the helm Sponsored: FROM CHOLERA TO COVID-19: How integrated data visualizations inform decisions and impact actions Praxis raises $110M to advance 3 clinical-phase CNS drugs AbbVie helps autoimmune startup Enthera to €28M A round Covance revenue hit hard as COVID-19 continues to drag on trial services FDA clears Zebra Medical's breast cancer AI for spotting suspicious mammography lesions Featured Story | By Ben Adams Pfizer and German biotech partner BioNTech have on the same day as rival Moderna kick-started a late-stage effort for their “best” attempt at an mRNA pandemic vaccine. read more |
| |
|---|
|
Top Stories By Ben Adams Sanofi’s immuno-oncology program leader Appoints Andrew Joe, M.D., has jumped ship from the French Big Pharma to Netherlands-based biotech Merus. read more By Amirah Al Idrus Versant Ventures is unveiling Bright Peak Therapeutics, a biotech working to improve how proteins work as drugs. Led by former Astellas Chief Medical Officer Sef Kurstjens, M.D., Ph.D., the company comes out of stealth with $35 million from Versant, technology licensed from ETH Zurich and a pipeline of cytokine treatments for cancer. read more By PerkinElmer, Inc How integrated data visualizations inform decisions and impact actions. Data visualization was first used to recognize disease patterns in the 1854 London cholera outbreak. It is even more essential today. read more By Nick Paul Taylor Praxis Precision Medicines has raised $110 million to take its three clinical-phase central nervous system treatments forward. The pipeline is led by a GABAA positive allosteric modulator that is closing in on the start of a pivotal trial in depression. read more By Nick Paul Taylor AbbVie has co-led a €28 million ($33 million) series A financing round in autoimmune startup Enthera Pharmaceuticals. The Italian biotech will use the money to take a molecule designed to restore the pancreatic beta cell compartment in Type 1 diabetes into the clinic. read more By Ben Adams Covance’s sales fell into the red this quarter as LabCorp’s CRO unit continues to battle major pandemic headwinds. read more By Conor Hale Zebra Medical Vision, developer of artificial-intelligence-based software for scanning X-ray images and automatically spotting critical health issues, has received its first FDA clearance in cancer screening. read more Resources Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: Cambrex The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet. Sponsored by: EVERSANA How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.” Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. 18th Annual Discovery on Target Virtual September 16-18, 2020 Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 